SU‐E‐T‐386: Improved Dose‐Response Relationship for Focal Cancer Therapy Using Liposome‐Encapsulated 186Re Radionuclides

B. Hrycushko, S. Ware, S. li, B. Goins, A. Bao

Research output: Contribution to journalArticle

Abstract

Purpose: Vital to all cancer therapy modalities, is an effective relationship between treatment and effect. This work evaluated this relationship for intratumoral infusions of liposome‐encapsulated, 186Re for the treatment of human head and neck squamous cell carcinoma xenografts in nude rats. Methods: Rats were separated into three treatment groups receiving intratumoral infusions of, 186Re‐liposomes (5mCi/cm3 tumor; infused volume = 45% tumor volume): one group received a single infusion location, one group received multiple (3) infusion locations, and one group received multiple (3) infusion locations following two systemically injected bevacizumab treatments (1mg/rat). Planar gamma camera imaging was used to obtain tumor clearance kinetics. SPECT/CT images were used to obtain intratumoral activity distributions. Tumor sizes were periodically measured up to 43 days post‐treatment. Intratumoral dose calculations were performed using a dose‐point‐kernel convolution technique with co‐registered SPECT/CT images. Average dose and EUD values were calculated for individual tumors in attempt to correlate values with relative tumor shrinkage by comparing day 43 tumor volumes with day 0.Results: Intratumoral dose calculations showed significant intratumoral dose heterogeneity. The use of three separate tumor infusion locations improved dose homogeneity compared to a single infusion location as a result of a more uniform radioactivity distribution. An excellent dose‐response correlation was seen with EUD calculations (R, 2 = 0.84) compared with average tumor doses (R, 2 = 0.22). Varying radiobiological parameters over commonly used values showed little effect on relative EUD calculations among rats and suggests individualized parameter use is of little significance as long as the intratumoral dose heterogeneity is taken into consideration in the dose‐response relationship. Conclusions: This work showed a much improved treatment‐effect relationship for intratumoral delivery of, 186Re‐liposomes when using tumor EUD calculations. This is useful for treatment planning and evaluation with this radiation delivery technique.

Original languageEnglish (US)
Pages (from-to)3576
Number of pages1
JournalMedical Physics
Volume38
Issue number6
DOIs
StatePublished - 2011

Fingerprint

Radioisotopes
Neoplasms
Therapeutics
Tumor Burden
Nude Rats
Heterografts
Radionuclide Imaging
Radioactivity
Radiation

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

SU‐E‐T‐386 : Improved Dose‐Response Relationship for Focal Cancer Therapy Using Liposome‐Encapsulated 186Re Radionuclides. / Hrycushko, B.; Ware, S.; li, S.; Goins, B.; Bao, A.

In: Medical Physics, Vol. 38, No. 6, 2011, p. 3576.

Research output: Contribution to journalArticle

Hrycushko, B. ; Ware, S. ; li, S. ; Goins, B. ; Bao, A. / SU‐E‐T‐386 : Improved Dose‐Response Relationship for Focal Cancer Therapy Using Liposome‐Encapsulated 186Re Radionuclides. In: Medical Physics. 2011 ; Vol. 38, No. 6. pp. 3576.
@article{d18139e426d940f3bf91a38ba9c1a11a,
title = "SU‐E‐T‐386: Improved Dose‐Response Relationship for Focal Cancer Therapy Using Liposome‐Encapsulated 186Re Radionuclides",
abstract = "Purpose: Vital to all cancer therapy modalities, is an effective relationship between treatment and effect. This work evaluated this relationship for intratumoral infusions of liposome‐encapsulated, 186Re for the treatment of human head and neck squamous cell carcinoma xenografts in nude rats. Methods: Rats were separated into three treatment groups receiving intratumoral infusions of, 186Re‐liposomes (5mCi/cm3 tumor; infused volume = 45{\%} tumor volume): one group received a single infusion location, one group received multiple (3) infusion locations, and one group received multiple (3) infusion locations following two systemically injected bevacizumab treatments (1mg/rat). Planar gamma camera imaging was used to obtain tumor clearance kinetics. SPECT/CT images were used to obtain intratumoral activity distributions. Tumor sizes were periodically measured up to 43 days post‐treatment. Intratumoral dose calculations were performed using a dose‐point‐kernel convolution technique with co‐registered SPECT/CT images. Average dose and EUD values were calculated for individual tumors in attempt to correlate values with relative tumor shrinkage by comparing day 43 tumor volumes with day 0.Results: Intratumoral dose calculations showed significant intratumoral dose heterogeneity. The use of three separate tumor infusion locations improved dose homogeneity compared to a single infusion location as a result of a more uniform radioactivity distribution. An excellent dose‐response correlation was seen with EUD calculations (R, 2 = 0.84) compared with average tumor doses (R, 2 = 0.22). Varying radiobiological parameters over commonly used values showed little effect on relative EUD calculations among rats and suggests individualized parameter use is of little significance as long as the intratumoral dose heterogeneity is taken into consideration in the dose‐response relationship. Conclusions: This work showed a much improved treatment‐effect relationship for intratumoral delivery of, 186Re‐liposomes when using tumor EUD calculations. This is useful for treatment planning and evaluation with this radiation delivery technique.",
author = "B. Hrycushko and S. Ware and S. li and B. Goins and A. Bao",
year = "2011",
doi = "10.1118/1.3612340",
language = "English (US)",
volume = "38",
pages = "3576",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - SU‐E‐T‐386

T2 - Improved Dose‐Response Relationship for Focal Cancer Therapy Using Liposome‐Encapsulated 186Re Radionuclides

AU - Hrycushko, B.

AU - Ware, S.

AU - li, S.

AU - Goins, B.

AU - Bao, A.

PY - 2011

Y1 - 2011

N2 - Purpose: Vital to all cancer therapy modalities, is an effective relationship between treatment and effect. This work evaluated this relationship for intratumoral infusions of liposome‐encapsulated, 186Re for the treatment of human head and neck squamous cell carcinoma xenografts in nude rats. Methods: Rats were separated into three treatment groups receiving intratumoral infusions of, 186Re‐liposomes (5mCi/cm3 tumor; infused volume = 45% tumor volume): one group received a single infusion location, one group received multiple (3) infusion locations, and one group received multiple (3) infusion locations following two systemically injected bevacizumab treatments (1mg/rat). Planar gamma camera imaging was used to obtain tumor clearance kinetics. SPECT/CT images were used to obtain intratumoral activity distributions. Tumor sizes were periodically measured up to 43 days post‐treatment. Intratumoral dose calculations were performed using a dose‐point‐kernel convolution technique with co‐registered SPECT/CT images. Average dose and EUD values were calculated for individual tumors in attempt to correlate values with relative tumor shrinkage by comparing day 43 tumor volumes with day 0.Results: Intratumoral dose calculations showed significant intratumoral dose heterogeneity. The use of three separate tumor infusion locations improved dose homogeneity compared to a single infusion location as a result of a more uniform radioactivity distribution. An excellent dose‐response correlation was seen with EUD calculations (R, 2 = 0.84) compared with average tumor doses (R, 2 = 0.22). Varying radiobiological parameters over commonly used values showed little effect on relative EUD calculations among rats and suggests individualized parameter use is of little significance as long as the intratumoral dose heterogeneity is taken into consideration in the dose‐response relationship. Conclusions: This work showed a much improved treatment‐effect relationship for intratumoral delivery of, 186Re‐liposomes when using tumor EUD calculations. This is useful for treatment planning and evaluation with this radiation delivery technique.

AB - Purpose: Vital to all cancer therapy modalities, is an effective relationship between treatment and effect. This work evaluated this relationship for intratumoral infusions of liposome‐encapsulated, 186Re for the treatment of human head and neck squamous cell carcinoma xenografts in nude rats. Methods: Rats were separated into three treatment groups receiving intratumoral infusions of, 186Re‐liposomes (5mCi/cm3 tumor; infused volume = 45% tumor volume): one group received a single infusion location, one group received multiple (3) infusion locations, and one group received multiple (3) infusion locations following two systemically injected bevacizumab treatments (1mg/rat). Planar gamma camera imaging was used to obtain tumor clearance kinetics. SPECT/CT images were used to obtain intratumoral activity distributions. Tumor sizes were periodically measured up to 43 days post‐treatment. Intratumoral dose calculations were performed using a dose‐point‐kernel convolution technique with co‐registered SPECT/CT images. Average dose and EUD values were calculated for individual tumors in attempt to correlate values with relative tumor shrinkage by comparing day 43 tumor volumes with day 0.Results: Intratumoral dose calculations showed significant intratumoral dose heterogeneity. The use of three separate tumor infusion locations improved dose homogeneity compared to a single infusion location as a result of a more uniform radioactivity distribution. An excellent dose‐response correlation was seen with EUD calculations (R, 2 = 0.84) compared with average tumor doses (R, 2 = 0.22). Varying radiobiological parameters over commonly used values showed little effect on relative EUD calculations among rats and suggests individualized parameter use is of little significance as long as the intratumoral dose heterogeneity is taken into consideration in the dose‐response relationship. Conclusions: This work showed a much improved treatment‐effect relationship for intratumoral delivery of, 186Re‐liposomes when using tumor EUD calculations. This is useful for treatment planning and evaluation with this radiation delivery technique.

UR - http://www.scopus.com/inward/record.url?scp=85029264057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029264057&partnerID=8YFLogxK

U2 - 10.1118/1.3612340

DO - 10.1118/1.3612340

M3 - Article

AN - SCOPUS:85029264057

VL - 38

SP - 3576

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -